| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Kyung-Ha Lee CEO | KRX SM Exchange | KR7096760004 ISIN |
| South Korea Country | 127 Employees | 31 Mar 2026 Last Dividend | 27 Dec 2018 Last Split | - IPO Date |
JW Holdings Corporation is a comprehensive healthcare company with a broad international presence, headquartered in Gwacheon-si, South Korea. Since its establishment in 1945, the company has expanded its operations to include a diverse range of healthcare products and services. Its operations encompass the development, manufacturing, and distribution of pharmaceuticals, medical devices, and various care products. The firm's commitment to improving healthcare standards globally is evident through its wide array of offerings and international operations.
JW Holdings Corporation's diverse portfolio spans across pharmaceuticals, medical devices, and care products. Each category includes specialized products designed to meet the needs of patients and healthcare providers.
The company manufactures intravenous solutions necessary for hydration, medication delivery, and nutritional support in clinical settings.
These products are essential for the safe and effective packaging and delivery of IV solutions, ensuring sterility and compatibility with various medications.
JW Holdings offers a range of medications, including carbapenem antibiotics for treating serious infections, along with other specialized and ETC (ethical pharmaceuticals) drugs for various conditions.
The provision of high-quality APIs facilitates the development and production of a wide array of pharmaceuticals by other companies, showcasing JW Holdings' role in supporting global healthcare.
The company's medical device portfolio includes a variety of essential hospital and clinical equipment:
Addressing the need for comprehensive care, JW Holdings offers products aimed at wound management, pain relief, and beauty care, demonstrating the company’s versatility in meeting a wide range of healthcare and personal care needs.